VBS.AX
Price:
$0.12
Market Cap:
$6.40M
Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure, which include treatments for heart, kidney, liver, and lung diseases. Its lead compound is VB0004, which is aimed at treating the loss of functional tissue to fibrosis, scarring, and high blood pressure. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops AccuCal and RealCount software that enhance speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. ...[Read more]
Industry
Biotechnology
IPO Date
2016-02-22
Stock Exchange
ASX
Ticker
VBS.AX
According to Vectus Biosystems Limited’s latest financial reports and current stock price. The company's current PE Ratio is -4.00. This represents a change of 167.84% compared to the average of -1.49 of the last 4 quarters.
The mean historical PE Ratio of Vectus Biosystems Limited over the last ten years is -6.30. The current -4.00 PE Ratio has changed 6.25% with respect to the historical average. Over the past ten years (40 quarters), VBS.AX's PE Ratio was at its highest in in the December 2011 quarter at 0. The PE Ratio was at its lowest in in the December 2012 quarter at -9.97.
Average
-6.30
Median
-6.90
Minimum
-9.85
Maximum
-1.20
Discovering the peaks and valleys of Vectus Biosystems Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 74.16%
Maximum Annual PE Ratio = -1.20
Minimum Annual Increase = -71.73%
Minimum Annual PE Ratio = -9.85
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.20 | -30.75% |
| 2024 | -1.73 | -71.73% |
| 2023 | -6.12 | -25.68% |
| 2022 | -8.23 | -16.43% |
| 2021 | -9.85 | 74.16% |
| 2020 | -5.66 | 13.56% |
| 2019 | -4.98 | -35.16% |
| 2018 | -7.68 | -10.91% |
| 2017 | -8.62 | -3.82% |
| 2016 | -8.96 | -32.36% |
The current PE Ratio of Vectus Biosystems Limited (VBS.AX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.01
5-year avg
-5.43
10-year avg
-6.30
Vectus Biosystems Limited’s PE Ratio is less than Bio-Gene Technology Limited (-2.63), greater than Invex Therapeutics Ltd (-18.99), less than Adherium Limited (-0.33), greater than Biotron Limited (-10.32), less than Acrux Limited (-1.08), less than Cann Group Limited (-0.21), less than Invion Limited (-0.84), less than InhaleRx Limited (-3.98), less than HITIQ Limited (-1.98), less than Memphasys Limited (-1.61),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.63 | $7.32M | |
| -18.99 | $9.02M | |
| -0.33 | $7.71M | |
| -10.32 | $4.98M | |
| -1.08 | $6.57M | |
| -0.21 | $5.63M | |
| -0.84 | $8.31M | |
| -3.98 | $5.71M | |
| -1.98 | $12.18M | |
| -1.61 | $9.82M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vectus Biosystems Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vectus Biosystems Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Vectus Biosystems Limited's PE Ratio?
How is the PE Ratio calculated for Vectus Biosystems Limited (VBS.AX)?
What is the highest PE Ratio for Vectus Biosystems Limited (VBS.AX)?
What is the 3-year average PE Ratio for Vectus Biosystems Limited (VBS.AX)?
What is the 5-year average PE Ratio for Vectus Biosystems Limited (VBS.AX)?
How does the current PE Ratio for Vectus Biosystems Limited (VBS.AX) compare to its historical average?